Published June 2015 | Version v1
Journal article

SU-E-T-294: Dosimetric Analysis of Planning Phase Using Overlap Volume Histogram for Respiratory Gated Radiotherapy

  • 1. The Catholic University of Korea College of Medicine, Seoul (Korea, Republic of)
  • 2. Virginia Commonwealth University, Richmond, VA (United States)
  • 3. Uijeongbu St.Mary's Hospital, GyeongGi-Do (Korea, Republic of)

Description

Purpose: End-of-exhale (EOE) phase is generally preferred for gating window because tumor position is more reproducible. However, other gating windows might be more appropriate for dose distribution perspective. In this pilot study, we proposed to utilize overlap volume histogram (OVH) to search optimized gating window and demonstrated its feasibility. Methods: We acquired 4DCT of 10 phases for 3 lung patients (2 with a target at right middle lobe and 1 at right upper lobe). After structures were defined in every phase, the OVH of each OAR was generated to quantify the three dimensional spatial relationship between the PTV and OARs (bronchus, esophagus, heart and cord etc.) at each phase. OVH tells the overlap volume of an OAR according to outward distance from the PTV. Relative overlap volume at 20 mm outward distance from the PTV (ROV-20) was also defined as a metric for measuring overlap volume and obtained. For dose calculation, 3D CRT plans were made for all phases under the same beam angles and objectives (e.g., 95% of the PTV coverage with at least 100% of the prescription dose of 50 Gy). The gating window phase was ranked according to ROV-20, and the relationship between the OVH and dose distribution at each phase was evaluated by comparing the maximum dose, mean dose, and equivalent uniform dose of OAR. Results: OVHs showed noticeable difference from phase to phase, implying it is possible to find optimal phases for gating window. For 2 out of 3 patients (both with a target at RML), maximum dose, mean dose, and EUD increased as ROV-20 increased. Conclusion: It is demonstrated that optimal phases (in dose distribution perspective) for gating window could exist and OVH can be a useful tool for determining such phases without performing dose optimization calculations in all phases. This work was supported by the Radiation Technology R&D program (No. 2013M2A2A7043498) and the Mid-career Researcher Program (2012-007883) through the National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning (MSIP) of Korea

Additional details

Identifiers

Publishing Information

Journal Title
Medical Physics
Journal Volume
42
Journal Issue
6
Journal Page Range
vp.
ISSN
0094-2405
CODEN
MPHYA6

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
47119407
Subject category
S60: APPLIED LIFE SCIENCES; S61: RADIATION PROTECTION AND DOSIMETRY;
Descriptors DEI
DOSIMETRY; ESOPHAGUS; HEART; LUNGS; NEOPLASMS; OPTIMIZATION; RADIATION DOSE DISTRIBUTIONS; RADIATION DOSES; RADIOTHERAPY; RESEARCH PROGRAMS
Descriptors DEC
BODY; CARDIOVASCULAR SYSTEM; DIGESTIVE SYSTEM; DISEASES; DOSES; MEDICINE; NUCLEAR MEDICINE; ORGANS; RADIOLOGY; RESPIRATORY SYSTEM; THERAPY

Optional Information

Notes
(c) 2015 American Association of Physicists in Medicine